TrialAmerican journal of hematology2015

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials.

Derralynn A Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.